![Antibodies and Immunodetection]( "Antibodies and Immunodetection")
CRISPR Gene Editing
Offering Cas Nucleases and sgRNA for non-viral CRISPR gene editing
Portfolio
Cas9 / Cas12a / Cas13a
Nucleases
Off-the-shelf Cas9, Cas12a and Cas13 nuclease products accelerate gene editing applications.
Learn More
GMP grade Cas9 nucleases fully support CRISPR gene editing from research to manufacturing.
Learn More
A powerful tool for creating gene knock-ins and knock-outs
Learn More
ssDNA and dsDNA HDR donor templates for effective gene knock-in
Learn More
Gene Editing Kits
and Antibodies
Including mutation detection kit, sgRNA screening and synthesis kits, and anti-Cas9/Cas12a antibodies.
Learn More
Legal Statement of GenCRISPR™ Services and Products
(Updated
on April 27, 2021):
- GenCRISPR™ services and products are covered under US 10,946,108, US 10,930,367, US
10,781,444, US 10,711,285, US 10,577,630, US 9,840,713, US 9,822,372, US 8,999,641, US 8,993,233, US
8,945,839, US 8,932,814, US 8,906,616, US 8,895,308, US 8,889,418, US 8,889,356, US 8,871,445, US
8,865,406, US 8,795,965, US 8,771,945, US 8,697,359 and foreign equivalents and licensed from Broad
Institute, Inc. Cambridge, Massachusetts, and US 10,000,772, US 10,113,167, US 10,227,611, US
10,266,850, US 10,301,651, US 10,308,961, US 10,337,029, US 10,351,878, US 10,358,658, US 10,358,659, US
10,385,360, US 10,400,253, US 10,407,697, US 10,415,061, US 10,421,980, US 10,428,352, US 10,443,076, US
10,487,341, US 10,513,712, US 10,519,467, US 10,526,619, US 10,533,190, US 10,550,407, US 10,563,227, US
10,570,419, US 10,577,631, US 10,597,680, US 10,612,045, US 10,626,419, US 10,640,791, US 10,669,560, US
10,676,759, US 10,752,920, US 10,774,344, US 10,793,878, US 10,900,054 and foreign equivalents and
licensed from ERS Genomics Limited.
- The products and the reagents generated from these services shall be used as tools for
research purposes, and shall exclude (a) any human or clinical use, including, without limitation, any
administration into humans or any diagnostic or prognostic use, (b) any human germline modification,
including modifying the DNA of human embryos or human reproductive cells, (c) any in vivo veterinary or
livestock use, or (d) the manufacture, distribution, importation, exportation, transportation, sale,
offer for sale, marketing, promotion or other exploitation or use of, or as, a testing service,
therapeutic or diagnostic for humans or animals.
- The purchase of the GenCRISPR™ Services and Products coveys to the
purchaser the limited, non-transferable right to use the products
purchased and the reagents generated from GenCRISPR™ services and any related material
solely for Research Purposes only, not for any Commercial Purposes.
